Identifying a maximum tolerated contour in two-dimensional dose finding.
about
A design for phase I trials in completely or partially ordered groups.Phase I Designs that Allow for Uncertainty in the Attribution of Adverse Events.Early phase dose finding methodology.Dose Finding for Drug Combination in Early Cancer Phase I Trials using Conditional Continual Reassessment Method.
P2860
Identifying a maximum tolerated contour in two-dimensional dose finding.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Identifying a maximum tolerated contour in two-dimensional dose finding.
@ast
Identifying a maximum tolerated contour in two-dimensional dose finding.
@en
type
label
Identifying a maximum tolerated contour in two-dimensional dose finding.
@ast
Identifying a maximum tolerated contour in two-dimensional dose finding.
@en
prefLabel
Identifying a maximum tolerated contour in two-dimensional dose finding.
@ast
Identifying a maximum tolerated contour in two-dimensional dose finding.
@en
P2860
P356
P1476
Identifying a maximum tolerated contour in two-dimensional dose finding.
@en
P2093
Nolan A Wages
P2860
P304
P356
10.1002/SIM.6918
P407
P577
2016-02-22T00:00:00Z